IBD (Inspire Corporate Bond ETF) Stock Analysis - Financials

Inspire Corporate Bond ETF (IBD) is a publicly traded the market company. As of May 21, 2026, IBD trades at $23.80 with a market cap of $0 and a P/E ratio of 0.00. IBD moved +0.00% today. Year to date, IBD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are IBD's key financials?

IBD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IBD recently traded at $23.80. Market cap is $0. P/E ratio is 0.00. Revenue is $0.

IBD Key Metrics

Key financial metrics for IBD
MetricValue
Price$23.80
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume139.86K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest IBD News

IBD Analyst Consensus

IBD analyst coverage data. Average price target: $0.00.

Common questions about IBD

What are IBD's key financials?
IBD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IBD recently traded at $23.80. Market cap is $0. P/E ratio is 0.00. Revenue is $0.
Is IBD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBD. It does not provide personalized investment advice.
IBD

IBD